Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sucrose non-fermenting-1-related protein kinase 1 (SnRK1) is a highly conserved serine/threonine kinase that serves as the primary energy sensor and metabolic regulator in plants (Baena-González et al., 2007, Nature). As the plant ortholog of the mammalian AMP-activated protein kinase (AMPK) and yeast SNF1, SnRK1 operates as a heterotrimeric complex consisting of alpha, beta, and gamma subunits (Broeckx et al., 2016, Frontiers in Plant Science). It is activated under conditions of energy deficit, such as darkness, hypoxia, or nutrient starvation, where it triggers a massive transcriptional and metabolic shift to maintain cellular homeostasis (Crepin and Rolland, 2019, Journal of Experimental Botany). SnRK1 promotes catabolic processes like autophagy and starch degradation while inhibiting energy-intensive anabolic pathways including protein and lipid synthesis (Wurzinger et al., 2018, Molecular Plant). In agricultural biotechnology, SnRK1 is a critical target for enhancing crop resilience to abiotic stresses like drought and salinity, as well as for optimizing carbon partitioning to improve harvest index (Nuccio et al., 2015, Nature Biotechnology). While not a traditional human therapeutic target, its central role in plant metabolism makes it a focus for developing chemical regulators to control plant growth and stress responses. The kinase is specifically inhibited by trehalose-6-phosphate (T6P), which signals high sucrose availability, creating a feedback loop that balances growth with available energy resources (Zhang et al., 2009, Plant Physiology).
SnRK1 acts as a metabolic master switch by phosphorylating key enzymes (such as HMG-CoA reductase and Nitrate reductase) and transcription factors (such as bZIP11 and bZIP63) to inhibit energy-consuming anabolic processes and activate energy-producing catabolic pathways during energy-deficit conditions.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sucrose non-fermenting-1-related protein kinase 1 (SnRK1).